In the last 5-10 years, there has been an increased awareness in the diagnosis and treatment of Sleep-Related Breathing Disorders and the associated co-morbidities associated with these disorders. Despite this increased awareness, 80-85% of the patients remain undiagnosed.
Sleep Apnea is common among stroke patients. It is estimated that two out of three people who suffer a stroke or a mini-stroke have the condition of obstructive sleep apnea.
A growing body of research is finding a link between sleep disorders and weight gain. And it can be a vicious cycle. Insufficient sleep can lead to weight gain, which can lead to sleep apnea, which produces more sleep deprivation and more packing on of the pounds.
Inflammation is our body’s immune system response. We need it to help fight infection and wounds. However, prolonged inflammation can lead to serious diseases and health issues.
Obstructive sleep apnea is a sleep disorder in which breathing is briefly and repeatedly interrupted during sleep. Excessive daytime sleepiness can be a result of interrupted sleep each night. Sleep apnea refers to a breathing pause that lasts at least ten seconds. Obstructive sleep apnea occurs when the muscles in the back of the throat fail to keep the airway open, despite efforts to breathe.
Snoring can do a lot more harm than just annoy your partner—it can lead to serious health issues. About 90 million Americans suffer from snoring; as many as half of those may have the sleep disorder Obstructive Sleep Apnea (OSA).
We look forward to Summer all year long. Travel, swimming, relaxing. All these activities are great and should be soaked up. But it is also important to be diligent about your sleep especially if you suffer from sleep apnea.
The dynamics of the Philips Respironics recall (WSJ: Roland, D, 8/17/21) requires all sleep physicians to consider non-CPAP therapies for patients diagnosed with Obstructive Sleep Apnea (OSA). The timeline for Philips to rectify their situation due to foam degradation and its consequences is unknown. Currently, ResMed PAP related devices are on backlog. Additionally, many of the 3 million patients affected by this recall may be reluctant to try CPAP again or simply prefer alternative treatment.
Over the last five to ten years we have observed thousands of patients diagnosed and treated for obstructive sleep apnea (OSA). As a result, we have seen a wide variety of patients who can’t tolerate CPAP and do much better with oral appliance therapy (OAT).
